The mortality rate of young female COVID-19 patients is reported to be lower than that of young males but no significant difference in mortality was found between female and male COVID-19 patients aged over 65 years, and the underlying mechanism is unknown. We retrospectively analyzed clinical characteristics and outcomes of severely ill pre- and post-menopausal COVID-19 patients and compared with age-matched males. Of the 459 patients included, 141 aged ≤55, among whom 19 died (16 males vs. 3 females, p<0.005). While for patients >55 years (n=318), 115 died (47 females vs. 68 males, p=0.149). In patients ≤55 years old, the levels of NLR, median LDH, median c-reactive protein and procalcitonin were significantly higher while the median lymphocyte count and LCR were lower in male than in female (all p<0.0001). In patients over 55, these biochemical parameters were far away from related normal/reference values in the vast majority of these patients in both genders which were in contrast to that seen in the young group. It is concluded that the mortality of severely ill pre-menopausal but not post-menopausal COVID-19 female patients is lower than age-matched male. Our findings support the notion that estrogen plays a beneficial role in combating COVID-19.
【저자키워드】 COVID-19, Mortality, Estrogen, severely, menopausal, 【초록키워드】 Clinical characteristics, LDH, Gender, procalcitonin, outcome, Lymphocyte count, Protein, male, female, Patient, mortality rate, mechanism, NLR, LCR, COVID-19 patient, Support, no significant difference, while, females, males, combating, analyzed, died, reported, median, majority, significantly higher, female patient, biochemical parameter, post-menopausal, pre-menopausal, the median, 【제목키워드】 Clinical characteristics, women, men, severe COVID-19 patient,